Intertek Expands Solar Market Footprint with New Acquisition
Intertek Group plc has acquired a state-of-the-art solar PV laboratory in Ahmedabad from Mitsui Chemicals India Pvt. Ltd. This acquisition enhances Intertek's capabilities in providing comprehensive testing services for solar PV installations, positioning the company as a leader in renewable energy assurance within the Indian market.
- Country:
- India
Intertek Group plc, a frontrunner in Total Quality Assurance solutions worldwide, has announced its acquisition of a cutting-edge solar photovoltaic (PV) laboratory in Ahmedabad, Gujarat. Previously owned by Mitsui Chemicals India Pvt. Ltd., the lab enhances Intertek's service offerings to the burgeoning solar industry as India strives for a significant renewable energy transformation.
With India's ambitious target set at 500 GW of non-fossil fuel power capacity by 2030, including 280 GW dedicated to solar energy, the demand for reliable Quality Assurance solutions has surged. Intertek's new solar PV lab, accredited with ISO 17025, will deliver comprehensive testing services. It aims to support both domestic solar PV manufacturers and international companies eager to tap into the Indian market by providing faster and more reliable market access through harmonized testing.
The latest acquisition bolsters Intertek's presence in the Western India corridor and strengthens its leadership in renewable energy assurance. This expansion aligns with the company's existing risk-based quality assurance offerings, including aerial and plant inspections. Ajay Kapoor, Regional Managing Director for South Asia at Intertek, emphasized the company's commitment to India's growing electrification process, while Sunny Rai, President of Electrical and Connected World at Intertek, highlighted the broader access solutions the lab provides for global solar players.
ALSO READ
India and Norway Seek to Overcome Trade Barriers for Economic Growth
Ensuring Safety: India's Coordinated Efforts in West Asia
Iran Conflict Triggers Price Surge in India's Pharmaceutical Sector
India Presses UK on Nirav Modi's Extradition Pledge
Urgent Call for National Haemophilia Treatment Guidelines in India

